Cargando…

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial

BACKGROUND: The occurrence of a venous thromboembolism (VTE) is common in patients with cancer. Gastric cancer has been associated with one of the highest risks for VTE. Chemotherapy, especially cisplatin has been associated with a high VTE risk. In this study, risk factors for VTE occurrence and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slagter, Astrid E., Sikorska, Karolina, Grootscholten, Cecile, van Laarhoven, Hanneke W. M., Lind, Pehr, Nordsmark, Marianne, Meershoek‐Klein Kranenbarg, Elma, van de Velde, Cornelis J. H., van Grieken, Nicole C. T., van Sandick, Johanna W., Jansen, Edwin P. M., Verheij, Marcel, Cats, Annemieke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520268/ https://www.ncbi.nlm.nih.gov/pubmed/32735752 http://dx.doi.org/10.1002/cam4.3118

Ejemplares similares

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2022)

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
por: Caspers, Irene A., et al.
Publicado: (2021)

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial
por: Slagter, Astrid E., et al.
Publicado: (2021)

Towards Personalization in the Curative Treatment of Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2020)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
por: Dikken, Johan L, et al.
Publicado: (2011)

Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
por: Biesma, Hedde D., et al.
Publicado: (2022)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
por: Leal, Alessandro, et al.
Publicado: (2020)

Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial
por: Claassen, Y. H. M., et al.
Publicado: (2018)

Extended lymph node dissection for gastric cancer from a European perspective
por: Dikken, Johan L., et al.
Publicado: (2011)

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer
por: Doeve, Benthe H., et al.
Publicado: (2023)

PD-1 The impact of COVID-19 on diagnosis, stage and treatment of esophageal and gastric cancer
por: Bakx, J., et al.
Publicado: (2022)

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study
por: van der Kaaij, Rosa T, et al.
Publicado: (2017)

Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer
por: Lee Meeuw Kjoe, Philippe R, et al.
Publicado: (2023)

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
por: Smit, Marloes, et al.
Publicado: (2019)

The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival
por: Houtsma, Danny, et al.
Publicado: (2021)

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX
por: Stroes, Charlotte I., et al.
Publicado: (2021)

Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study
por: Nagtegaal, Iris D, et al.
Publicado: (2001)

Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014
por: Punt, Cornelis JA, et al.
Publicado: (2015)

Health-Related Quality of Life in Locally Advanced Gastric Cancer: A Systematic Review
por: van Amelsfoort, Romy M., et al.
Publicado: (2021)

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer
por: van Velzen, Merel J. M., et al.
Publicado: (2023)

Thromboembolic and bleeding complications in patients with oesophageal cancer
por: Mulder, F. I., et al.
Publicado: (2020)

Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
por: Derks, Sarah, et al.
Publicado: (2022)

The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
por: van Laarhoven, Hanneke W.M., et al.
Publicado: (2023)

SPOTlight on GLOW
por: Derks, Sarah, et al.
Publicado: (2023)

Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control
por: Prata, Ilaria, et al.
Publicado: (2023)

High Functioning Autism Spectrum Disorders in Adults: Consequences for Primary Caregivers Compared to Schizophrenia and Depression
por: Grootscholten, Inge A. C., et al.
Publicado: (2018)

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
por: de Groot, S., et al.
Publicado: (2015)

Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
por: Hospers, Geke A., et al.
Publicado: (2007)

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
por: de Groot, Stefanie, et al.
Publicado: (2019)

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
por: Zhang, Xi, et al.
Publicado: (2023)

Children’s sugar-sweetened beverages consumption: associations with family and home-related factors, differences within ethnic groups explored
por: van de Gaar, V. M., et al.
Publicado: (2017)

Emerging targets in gastroesophageal adenocarcinoma: what the future looks like
por: Petrillo, Angelica, et al.
Publicado: (2023)

The Use of (Network) Meta-Analysis in Clinical Oncology
por: ter Veer, Emil, et al.
Publicado: (2019)

Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)
por: Temmink, Sofieke J D, et al.
Publicado: (2023)

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial
por: Dijkstra, Esmée A., et al.
Publicado: (2023)

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
por: Manoukian, Paul, et al.
Publicado: (2021)

Muslim physicians and palliative care: attitudes towards the use of palliative sedation
por: Muishout, George, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q4d93hpmqcrsv2j8vedj83rutk